Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
暂无分享，去创建一个
B. Leggett | F. Nevens | K. Kowdley | M. Shiffman | M. Swain | P. Trivedi | M. Heneghan | G. Hirschfield | C. Corpechot | C. Bowlus | E. Janczewska | Yunjung Choi | E. Zuckerman | S. Gordon | P. Andreone | L. Forman | P. Invernizzi | E. Lawitz | E. Zigmond | C. Levy | R. Aspinall | M. S. González-Huezo | G. Dalekos | E. Fassio | S. Ryder | P. Boudes | A. Kremer | D. Pratt | J. Vierling | H. Hinrichsen | M. Mayo | A. Steinberg | S. Jeong | A. Gulamhusein | David Jones | J. Drenth | Victor Vargas | K. Raikhelson | C. McWherter | Alma L. Ladrón de Guevara | Yun-Jung Choi | Ehud Zigmond | Charles A. McWherter